Zein-polycaprolactone core–shell nanofibers for wound healing

https://doi.org/10.1016/j.ijpharm.2022.121809Get rights and content
Under a Creative Commons license
open access

Highlights

  • Coaxial electrospinning can be used to produce zein-PCL nanofibers.

  • Sustained antimicrobial drug release can be achieved from zein-PCL nanofibers.

  • Zein-PCL nanofibers are water stable, ductile and show good mechanical strength.

  • Zein-PCL nanofibers with T show good antimicrobial activity and cytocompatibility.

  • Zein-PCL nanofiber scaffolds allow attachment of fibroblasts.

Abstract

In a previous study, we developed electrospun antimicrobial microfiber scaffolds for wound healing composed of a core of zein protein and a shell containing polyethylene oxide. While providing a promising platform for composite nanofiber design, the scaffolds showed low tensile strengths, insufficient water stability, as well as burst release of the antimicrobial drug tetracycline hydrochloride, properties which are not ideal for the use of the scaffolds as wound dressings. Therefore, the aim of the present study was to develop fibers with enhanced mechanical strength and water stability, also displaying sustained release of tetracycline hydrochloride. Zein was chosen as core material, while the shell was formed by the hydrophobic polymer polycaprolactone, either alone or in combination with polyethylene oxide. As compared to control fibers of pristine polycaprolactone, the zein-polycaprolactone fibers exhibited a reduced diameter and hydrophobicity, which is beneficial for cell attachment and wound closure. Such fibers also demonstrated sustained release of tetracycline hydrochloride, as well as water stability, ductility, high mechanical strength and fibroblast attachment, hence representing a step towards the development of biodegradable wound dressings with prolonged drug release, which can be left on the wound for a longer time.

Keywords

Biomaterial
Coaxial electrospinning
Sustained release
Tissue regeneration

Abbreviations

AA
acetic acid
DL
drug loading
ECM
extracellular matrix
EDTA
ethylenediaminetetraacetic acid
EE
encapsulation efficiency
EMA
European Medicines Agency
FDA
Food and Drug Administration
LB
Luria-Bertani
LDH
lactate dehydrogenase
MDSC
modulated differential scanning calorimetry
MQ
Milli-Q deionized water
MTT
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
NFM
nanofiber mat
OD
optical density
PBS
phosphate-buffered saline
PCL
polycaprolactone
25PCL
fibers composed of pristine polycaprolactone
PEO
polyethylene oxide
RT
room temperature
SD
standard deviation
SEM
scanning electron microscopy
T
tetracycline hydrochloride
TDL
theoretical drug loading
T25PCL
fibers composed of pristine polycaprolactone and tetracycline hydrochloride
XRD
X-ray diffraction
zein-25PCL
core–shell fibers containing zein in the core and 25 % PCL in the shell
zeinT-25PCL
core–shell fibers containing zein and tetracycline hydrochloride in the core and 25 % PCL in the shell
zein-1PEO/1PCL
core–shell fibers containing zein in the core and 1 % PEO as well as 1 % PCL in the shell
zeinT-1PEO/1PCL
core–shell fibers containing zein and tetracycline hydrochloride in the core and 1 % PEO as well as 1 % PCL in the shell
zein-1PEO/3PCL
core–shell fibers containing zein in the core and 1 % PEO as well as 3 % PCL in the shell
zeinT-1PEO/3PCL
core–shell fibers containing zein and tetracycline hydrochloride in the core and 1 % PEO as well as 3 % PCL in the shell

Cited by (0)

1

Current address.